Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma

Noh, KH; Lee, SH; Lee, H; Jeong, AJ; Kim, KO; Shin, HM; Kim, HR; Park, MJ; Park, JB; Lee, J; Ye, SK

Ye, SK (通讯作者),Seoul Natl Univ, Dept Pharmacol & Biomed Sci, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.

TRANSLATIONAL ONCOLOGY, 2022; 15 (1):

Abstract

The resistance of highly aggressive glioblastoma multiforme (GBM) to chemotherapy is a major clinical problem resulting in a poor prognosis. GBM conta......

Full Text Link